source
- Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast CancerCapivasertib plus fulvestrant generated a numerical OS benefit vs placebo plus fulvestrant in PIK3CA/AKT1/PTEN-altered advanced breast cancer.onclive · 2mo ago↗ source
- Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary IslandsSpanish authorities on Friday were preparing to receive more than 140 passengers and crew members on board a hantavirus-stricken cruise ship headed for the Canary Islands.STAT · 2mo ago↗ source
- STAT+: Roche to buy PathAI for $750 millionRoche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.STAT